Related by context. All words. (Click for frequent words.) 73 potentially modifiable 64 NAFLD 64 cardiovascular disease 64 abnormal lipids 63 modifiable lifestyle 63 metabolic abnormalities 63 multifactorial 63 elevated triglycerides 63 gallstone disease 62 cardiovascular disease CVD 62 cardiovascular mortality 62 insulin resistance 62 hereditary predisposition 62 carotid atherosclerosis 61 metabolic syndrome 61 subclinical atherosclerosis 61 lipid abnormalities 61 modifiable cardiovascular 61 hypovitaminosis D 61 subclinical hypothyroidism 61 abdominal obesity 61 cardiometabolic risk 61 coronary heart 61 Singh Manoux 61 subclinical hyperthyroidism 60 elevated CRP 60 Genetic variants 60 folate intake 60 MetS 60 polyp recurrence 60 thromboembolic disease 60 atherogenic dyslipidemia 60 macrovascular disease 60 postmenopausal breast cancer 60 cardiovascular disease hypertension 59 diabetes hyperlipidemia 59 dysglycemia 59 coronary artery disease 59 Vitamin D insufficiency 59 Genetic predisposition 59 cardio vascular disease 59 microvascular disease 59 Physical inactivity 59 hypertension 59 co morbidities 59 systolic hypertension 59 glucose intolerance 59 dietary patterns 59 cerebral infarction 59 heart disease 59 thyroid dysfunction 58 nonadherence 58 prostate carcinogenesis 58 thrombophilia 58 predisposing factors 58 obesity sedentary lifestyle 58 vitamin D deficiency 58 cardiovascular morbidity 58 vascular inflammation 58 atherothrombotic disease 58 hypercalciuria 58 genetic polymorphisms 58 familial pancreatic cancer 58 spontaneous preterm birth 58 abnormal lipid 58 inherited predisposition 58 microbleeds 58 insulin resistance syndrome 58 venous thrombosis 58 obesity insulin resistance 58 predisposing factor 58 atherothrombosis 58 macrovascular events 58 familial clustering 58 transferrin saturation 58 familial hypercholesterolemia 58 Prehypertension 58 depressive disorders 58 impaired glucose metabolism 57 disease NAFLD 57 endometrial hyperplasia 57 familial adenomatous polyposis 57 folate deficiency 57 serum vitamin D 57 LQTS 57 colorectal neoplasia 57 albuminuria 57 comorbidity 57 body fatness 57 KIF6 carriers 57 gestational diabetes 57 polycystic ovary syndrome 57 androgen deficiency 57 lipid levels 57 colorectal adenoma 57 thrombotic events 57 atherosclerosis 57 dyslipidaemia 57 periodontal disease 57 MYH9 57 colorectal adenomas 57 etiologic 57 dietary antioxidants 57 SRBD 57 vitamin B# deficiency 57 preterm delivery 57 genetic susceptibility 57 comorbid conditions 57 polycystic ovary syndrome PCOS 57 hyperkalemia 57 ORMDL3 57 hypertension diabetes mellitus 57 carotid stenosis 57 sleep disordered breathing 57 gestational diabetes mellitus 57 underdiagnosis 57 microvascular complications 57 obstetric complications 57 APOE e4 57 inflammatory rheumatic 57 diabetes dyslipidemia 56 multi factorial disease 56 cardioembolic stroke 56 underlying pathophysiology 56 coronary artery calcification 56 periodontal diseases 56 cardiovascular diseases 56 gastro oesophageal reflux 56 hyperglycaemia 56 Polycystic ovary syndrome PCOS 56 comorbid depression 56 atherosclerotic vascular disease 56 hyperphosphatemia 56 Homocysteine 56 AUDs 56 elevated homocysteine 56 atherothrombotic 56 osteoporotic fracture 56 hypertension hypercholesterolemia 56 type2 diabetes 56 arterial calcification 56 chronic obstructive lung 56 CVD mortality 56 causal pathway 56 elevated LDL cholesterol 56 Hypertriglyceridemia 56 carotid plaque 56 coronary disease 56 prediabetes 56 Nonalcoholic fatty liver 56 genetic variants 56 epigenetic changes 56 slow metabolizers 56 nonfasting triglyceride levels 56 bicuspid aortic valves 56 Leitzmann 56 Vitamin B# deficiency 56 lipid disorders 56 nonfasting triglycerides 56 nonalcoholic steatohepatitis 56 etiological factors 56 pathophysiologic 56 elevated triglyceride levels 56 autonomic dysfunction 56 obstructive sleep apnea 56 comorbidities 56 premenopausal breast cancer 56 fructose intake 56 genetic variants associated 56 adenomatous polyps 56 MGUS 56 chronic diseases 56 Chronic insomnia 55 atopic disease 55 socioeconomic gradient 55 dyslipidemia hypertension 55 Erythropoietic therapies may 55 asthma exacerbations 55 DVT PE 55 microalbuminuria 55 coinfection 55 biologic pathways 55 MYH9 gene 55 dietary sodium 55 Excessive daytime sleepiness 55 mood disorders 55 etiologic factors 55 systemic inflammation 55 C reactive protein 55 genetic determinants 55 de ath 55 Secondhand smoke exposure 55 preterm deliveries 55 narcolepsy cataplexy 55 cardio metabolic 55 Nonalcoholic Fatty Liver Disease 55 atherosclerotic disease 55 Framingham Offspring Study 55 OSAHS 55 etiological 55 periodontal infections 55 endometriosis ovarian cysts 55 cryptogenic stroke 55 abdominal adiposity 55 COPD 55 vitamin D insufficiency 55 underactive thyroid gland 55 osteoporotic fractures 55 Epidemiologic studies 55 Sudden Cardiac Death 55 abnormal lipid levels 55 antioxidant supplementation 55 neurodevelopmental outcomes 55 prostate cancer CaP 55 BRCA2 mutations 55 persistent pulmonary hypertension 55 mammographic density 55 perinatal depression 55 coronary calcification 55 diabetes mellitus DM 55 psychiatric comorbidity 55 hyperhomocysteinemia 55 hypertensives 55 diabetes cardiovascular disease 55 chorioamnionitis 55 juvenile idiopathic arthritis 55 hsCRP 55 dyslipidemia 55 coronary artery calcium 55 antiphospholipid syndrome 55 cardiac insufficiency 55 dietary sodium intake 55 susceptibility gene 55 recurrent miscarriages 55 dietary calcium intake 55 Hypertensive 55 statin therapy 55 G6PD deficiency 55 silent myocardial ischemia 55 HNSCC 55 Ascherio 55 thyroid hormone levels 55 nonalcoholic fatty liver 55 calcium supplementation 55 menstrual irregularity 55 habitual snoring 55 Periodontal disease 55 LV dysfunction 55 postoperative AF 55 fibroids endometriosis 55 metabolic disturbances 55 preeclampsia 55 thyrotropin levels 55 physiologic mechanisms 55 hydroxyvitamin D levels 55 familial predisposition 55 APOE genotype 55 lipoprotein metabolism 55 hypercholesterolemia 55 recurrent miscarriage 55 vascular disease 55 fatty liver disease 55 spontaneous preterm delivery 55 unmeasured factors 55 chronic thromboembolic pulmonary 55 nicotine dependence 55 unhealthy dietary habits 55 AAT deficiency 55 hyperinsulinemia 55 Sleep disordered breathing 55 Pre eclampsia 55 hs CRP 55 Major depressive disorder 55 dietary folate 54 alcoholic fatty liver 54 MTHFR 54 anovulatory infertility 54 plasma lipid 54 Cognitive impairment 54 folic acid intake 54 antenatal depression 54 Dental caries 54 Periodontitis 54 airway hyperresponsiveness 54 primary ovarian insufficiency 54 related maculopathy 54 statin medications 54 NOMID 54 metabolic dysfunction 54 CHD mortality 54 fragility fractures 54 cardiac dysfunction 54 Cardiovascular Risk 54 chronic pancreatitis 54 colorectal polyps 54 shorter telomere length 54 Comorbid 54 gynecologic malignancy 54 CVD cardiovascular disease 54 APOE gene 54 BRCA1 mutations 54 confounding variables 54 uncontrolled asthma 54 neonatal morbidity 54 adiponectin levels 54 multisystem disease 54 serum calcium 54 susceptibility genes 54 menarche 54 Thiazolidinediones 54 Hyperlipidemia 54 Iron deficiency anemia 54 Lp PLA2 54 antihypertensive medications 54 Insulin resistance 54 serum uric acid 54 SE alleles 54 postoperative delirium 54 congenital abnormalities 54 recurrent abdominal pain 54 diabetes mellitus 54 CHD CVD 54 chronic periodontitis 54 serum leptin 54 thromboembolic 54 lipid parameters 54 neuropsychiatric disorders 54 Vitamin D supplementation 54 chlamydia infection 54 hyperparathyroidism 54 iodine intake 54 PAOD 54 magnesium intake 54 Boden Albala 54 stratifying patients 54 circulating estrogens 54 nonmelanoma skin cancer 54 TGFBR1 * 6A 54 Uncontrolled hypertension 54 IPAH 54 carotid bruit 54 obstructive coronary artery 54 saturated fat intake 54 Obstructive sleep apnea 54 leiomyomas 54 T1DM 54 advanced adenoma 54 dietary intake 54 testosterone supplementation 54 proliferative diabetic retinopathy 54 Prematurity 54 serum phosphate 54 etiology 54 Proteinuria 54 Vitamin D deficiency 54 unfavorable prognostic 54 fatal IHD 54 neurocognitive deficits 54 maternal morbidity 54 congenital anomalies 54 gastro oesophageal reflux disease 54 atherosclerosis hardening 54 Coronary artery calcification 54 renal scarring 54 carotid plaques 54 Heavy snorers 54 heterozygous familial 54 congenital malformations 54 Calcium intake 54 periodontitis 54 Fatty liver 54 Prediabetes 54 root caries 54 colorectal cancer CRC 54 comorbid anxiety 54 vascular dysfunction 54 vitamin D supplementation 54 pre menopausal 54 adiponectin 54 impaired cognition 54 subfertility 54 endometrial cancer 54 chronic bilirubin encephalopathy 54 Pulmonary hypertension 54 FGFR2 gene 54 venous blood clots 54 Hypertension 54 nonalcoholic steatohepatitis NASH 54 obese postmenopausal 54 myocardial fibrosis 54 hereditary breast cancer 54 carotid IMT 54 postmenopausal hormone 54 Chronic inflammation 53 benign breast 53 postoperative pulmonary 53 irreversible blindness 53 Pseudomonas aeruginosa infections 53 CP CPPS 53 basal cell nevus syndrome 53 unmeasured confounders 53 arterial stiffening 53 vitamin D inadequacy 53 post thrombotic syndrome 53 hyperlipidaemia 53 postoperative atrial fibrillation 53 non fasting triglycerides 53 fasting glucose levels 53 distal colon cancer 53 Exacerbations 53 serum folate concentrations 53 asymptomatic bacteriuria 53 calcium intake 53 central adiposity 53 precursor lesions 53 upper gastrointestinal bleeding 53 sudden cardiac death 53 polycystic ovary 53 blood lipids 53 INTERHEART study 53 lobular breast cancer 53 untreated sleep apnea 53 Obstructive Sleep Apnea 53 chromium supplementation 53 Elevated triglycerides 53 bronchial hyperresponsiveness 53 endometrial cancers 53 untreated celiac disease 53 Diabetes mellitus 53 Coronary artery disease 53 antiplatelet agents 53 IUGR 53 recurrent wheezing 53 untreated hypothyroidism 53 ABCB1 53 preterm birth 53 colorectal cancer 53 adiposity 53 dietary glycemic index 53 Elevated CRP 53 Postnatal depression 53 cerebrovascular diseases 53 Cristofanilli 53 esophageal adenocarcinoma 53 nonvertebral fractures 53 dysfunctional voiding 53 Genetic variations 53 beta carotene supplementation 53 Fecal particles 53 abnormal vaginal bleeding 53 dopaminergic therapy 53 kidney dysfunction 53 Observational studies 53 endothelial dysfunction 53 primary aldosteronism 53 dietary fat 53 noncardiovascular mortality 53 myocardial ischaemia 53 venous thromboembolism 53 Wernicke encephalopathy 53 Oxidative damage 53 underactive thyroid 53 precancerous cervical 53 antihypertensive therapy 53 depressive symptomatology 53 glycated hemoglobin levels 53 extrapyramidal symptoms 53 BRCA mutation 53 Cholesterol Levels SPARCL 53 Inhaled corticosteroids 53 chlamydial infection 53 morbidities 53 poorer prognosis 53 cardiac conduction 53 Ischemic heart 53 Chlamydia infection 53 gum disease 53 abdominally obese 53 utero exposure 53 metabolic syndrome clustering 53 uncontrolled epilepsy 53 tumor histology 53 hypercholesterolaemia 53 RBP4 53 inherited mutations 53 residual confounding 53 von Willebrand disease 53 prognostic indicators 53 aneurysmal rupture 53 venous thromboembolic disease 53 fetal malformations 53 mitochondrial dysfunction 53 Aortic stenosis 53 density lipoprotein cholesterol 53 inflammatory markers 53 hypothalamic pituitary adrenal axis 53 musculo skeletal pain 53 myocardial infarctions MIs 53 subclinical 53 diabetes mellitus hypertension 53 gene variants 53 Pischon 53 IgA deficiency 53 Sarcopenia 53 Generalized anxiety disorder 53 susceptibility loci 53 obese adolescents 53 polyarticular 53 Stroke Risk 53 POAG 53 dietary fiber intake 53 atherosclerotic cardiovascular disease 53 rheumatic disease 53 pathogenesis 53 genetic variant 53 waist circumference 53 Von Willebrand disease 53 cirrhotic patients 53 secondary hyperparathyroidism 53 Gastric cancer 53 inflammatory biomarkers 53 polycystic ovarian syndrome PCOS 53 urolithiasis 53 neuroinflammation 53 squamous cell lung cancer 53 thyrotropin 53 coagulation abnormalities 53 impair fertility 53 diabetic retinopathy 53 left ventricular hypertrophy 53 esophageal squamous cell carcinoma 53 Hypothyroidism 53 beta carotene supplements 53 Hypertrophic cardiomyopathy 53 lowering LDL cholesterol 53 impaired glucose tolerance 53 comorbid psychiatric 53 HDL C 53 atypical antipsychotic medications 52 postmenopausal hormone replacement 52 elevated IOP 52 hyperphenylalaninemia HPA due 52 thrombotic complications 52 macrovascular complications 52 glycemic diet 52 fructose intolerance 52 atopic eczema 52 CMV infection 52 amino acid homocysteine 52 disordered eating behaviors 52 Venous thromboembolism 52 postmenopausal women 52 atherosclerotic cardiovascular 52 obesity 52 lipoprotein levels 52 AA Amyloidosis 52 asthma rhinitis 52 neuropsychiatric disorder 52 impaired fasting glucose 52 preventive cardiologist 52 arterial stiffness 52 serum cholesterol 52 antihypertensive medication 52 atopic disorders 52 cerebral microbleeds 52 physical inactivity 52 recurrent VTE 52 chronicity 52 #mg/dL [001] 52 carbohydrate intolerance 52 Premenopausal women 52 reflux disease 52 myeloproliferative diseases 52 dentinal hypersensitivity 52 recurrent UTI 52 Urinary tract infection 52 genetic locus 52 pulmonary hypertension PH 52 breast cancer susceptibility genes 52 neurological abnormalities 52 pathophysiological processes 52 premenopausal women 52 macrovascular 52 metabolic syndrome MetS 52 causal pathways 52 microdeletions 52 Ovary removal 52 irregular menstrual cycles 52 prognostic markers 52 Comorbidities 52 XMRV infection 52 perimenopausal women 52 pharmacologic intervention 52 HNPCC 52 pathogenic mechanisms 52 prognostic significance 52 inherited metabolic disorders 52 genetic syndromes 52 H. pylori infection 52 preterm births 52 hyperoxaluria 52 recurrent venous thromboembolism 52 calcium metabolism 52 pharmacologic treatments 52 haemochromatosis 52 STAT4 52 genetic predisposition 52 latent TB infection 52 Hashimoto thyroiditis 52 Disease GOLD 52 hypoglycemic episodes 52 muscular dystrophies 52 prescribe statins 52 metabolic dysregulation 52 gene variant 52 HIV HCV coinfected 52 NKX2 52 prenatal exposures 52 atypical hyperplasia 52 Statin therapy 52 autoimmune thyroid 52 Zinc deficiency 52 Polycystic Ovary Syndrome 52 Irritable bowel syndrome IBS 52 cardiac hypertrophy 52 familial adenomatous polyposis FAP 52 neurologic complications 52 rheumatic diseases 52 highly heritable 52 oesophageal adenocarcinoma 52 probiotic supplementation 52 vitamin D intake 52 triglyceride levels 52 Abdominal obesity 52 #q#.# deletion syndrome 52 glitazones 52 fasting insulin 52 unknown etiology 52 mtDNA mutations 52 cognitive dysfunctions 52 hyperbilirubinemia 52 lipid lowering therapy 52 Waist circumference 52 periodontal infection 52 lipohypertrophy 52 Maternal obesity 52 Metabolic Syndrome 52 ichthyosis vulgaris 52 myocardial infarction MI 52 androgen excess 52 diffuse gastric 52 aetiology 52 preserved ejection fraction 52 adrenal function 52 MD ScD 52 Osteopenia 52 atherosclerotic 52 microscopic hematuria 52 Subclinical 52 diabetic microvascular complications 52 skeletal fluorosis 52 comorbid disorders 52 renal impairment 52 bladder cancers 52 ischemic stroke 52 acute myocardial infarction MI 52 leptin resistance 52 nephrolithiasis 52 T2DM 52 plasma homocysteine levels 52 serum triglycerides 52 T2D 52 vertebral fracture 52 V Leiden 52 non ulcer dyspepsia 52 Alzheimer Disease AD 52 STEP BD 52 FGFR2 52 hyperlipidemia hypertension 52 mixed hyperlipidemia 52 cardiovascular disease osteoporosis 52 Helicobacter pylori infection 52 Bronchiectasis 52 neuro developmental 52 Neurological disorders 52 prognostic marker 52 antidiabetic medication 52 thyroid function 52 Chronic Heart Failure 52 pathophysiological mechanisms 52 cerebral vascular disease 52 exhaled nitric oxide 52 ATACAND 52 chromosomal alterations 52 lichen planus 52 folate supplementation 52 nongenetic 52 genetic loci 52 Interstitial cystitis 52 atherosclerotic coronary 52 TCF#L# 52 GBA mutations 52 atopic 52 endocrine abnormalities 52 neuroinflammatory 52 TCF#L# gene 52 hyperlipidemia 52 angina chest 52 LUTS 52 HDL cholesterol 52 Alzheimer pathology 52 Heavy menstrual bleeding 52 dietary modification 52 resistant hypertension 52 iron overload 52 lipid lowering medications 52 Adenomas 52 bowel cancers 52 Hypoglycemia 52 CHD coronary 52 SORL1 52 obstructive lung 52 cardioprotective effects 52 Anxiety disorders 52 macroalbuminuria 52 C. pneumoniae 52 thromboembolism 52 abnormal glucose tolerance 52 prothrombotic 52 colon polyps 52 antihypertensive drugs 52 #,# DCB 52 APOE4 52 giant cell arteritis 52 congenital toxoplasmosis 52 RSV infections 52 Chronic pancreatitis 52 Cardiovascular Events 52 neurodevelopmental outcome 52 advanced adenomas 52 multi factorial 52 HeFH 52 statins cholesterol lowering 52 testicular tumors 52 hypertensive patients 52 Apolipoprotein E 52 bowel polyps 51 antipsychotic induced 51 cystatin C 51 bile acid metabolism 51 pulmonary embolism PE 51 comorbid psychiatric disorders 51 APOL1 51 Anorexia nervosa 51 Sleep disturbances 51 Stop Hypertension diet 51 neurocognitive impairment 51 VUR 51 vegetable intake 51 C Reactive Protein 51 beta blocker therapy 51 Invasive Breast Cancer 51 multifactorial disease 51 Viral hepatitis 51 PLMs 51 lipid elevations 51 Stop Hypertension DASH diet 51 elevated LDL 51 disc degeneration 51 myeloproliferative neoplasms 51 overactive bladder symptoms 51 chromosomal disorders 51 antiplatelet drugs 51 maintaining cardiorespiratory fitness 51 gestational hypertension 51 inflammatory bowel syndrome 51 mitochondrial mutations 51 Endometrial cancer 51 carbohydrate metabolism 51 biologic plausibility 51 periodontal gum disease 51 thyroid nodules 51 abnormal glucose metabolism 51 bronchopulmonary dysplasia 51 uric acid levels 51 BRCA carriers 51 #q# deletion 51 recurrent atrial fibrillation 51 multisymptom illness 51 prediabetic 51 induce orthostatic hypotension 51 filaggrin mutations 51 myocardial infarctions 51 intensive statin therapy 51 Endothelial dysfunction 51 AI AN 51 Coronary heart 51 zinc deficiency 51 neuropsychiatric symptoms 51 structural abnormalities 51 serum parathyroid hormone 51 pneumococcal infection 51 FeNO 51 Retinopathy 51 rhinovirus infection 51 torsade de pointes 51 postsurgical complications 51 Vascular Disease 51 chronic prostatitis 51 behavioral disinhibition 51 hepatocellular carcinoma liver 51 aetiological 51 Subtypes 51 COPD exacerbations 51 folic acid deficiency 51 PTEN mutations 51 clinically heterogeneous 51 Cognitive Impairment 51 Thyroid disorders 51 variceal bleeding 51 testicular germ cell 51 Aggressive Reduction 51 LDL HDL 51 leukotriene pathway 51 molecular abnormalities 51 triacylglycerol concentrations 51 Polycystic Ovarian Syndrome PCOS 51 microvascular syndrome 51 lipid profiles 51 hypertriglyceridemia 51 pre eclampsia 51 Hyperkalemia 51 arterial hypertension 51 colorectal carcinogenesis 51 Peripheral artery disease 51 cryptogenic 51 dietary intakes 51 thyrotoxicosis 51 hippocampal volume 51 STRIDE PD 51 molecular mechanisms underlying 51 chromosome #p#.# 51 intraventricular hemorrhage 51 proteinuria 51 progressive neurodegenerative disorder 51 comorbid 51 untreatable blindness 51 intestinal polyps 51 CLA supplementation 51 telomere lengths 51 socioeconomic status 51 Heritability 51 variant angina 51 ovarian pancreatic 51 improves insulin sensitivity 51 metabolic abnormality 51 Bairey Merz 51 elevated fasting glucose 51 angiotensin receptor blockers ARBs 51 death syndrome SIDS 51 pharmacological intervention 51 elevated uric acid 51 diabetic kidney 51 dietary folate intake 51 urate levels 51 remnant lipoproteins 51 Dyslipidemia 51 chronic hepatitis cirrhosis 51 coronary artery atherosclerosis 51 knee OA 51 Blood Cholesterol 51 allergic sensitization 51 Microalbuminuria 51 intracranial stenosis 51 breast endometrial 51 endometrial kidney 51 leptin deficiency 51 hepatitis B infection 51 hyperglycemia 51 glycemia 51 Impaired glucose tolerance 51 abnormal pap smears 51 Morbid obesity 51 respiratory viral infections 51 Diabetic Retinopathy 51 Diabetic nephropathy 51 asymptomatic carotid stenosis 51 pharmacological approaches 51 ApoE4 gene 51 primary biliary cirrhosis 51 severe periodontitis 51 prognostic factors 51 MCAD deficiency 51 monogenic 51 MYCN amplification 51 metabolic disorders 51 MD tells WebMD 51 cardiorespiratory fitness 51 glycemic index diets 51 rhinosinusitis 51 LRP5 51 Premature Ovarian Failure 51 hypoxemia 51 reflux symptoms 51 selenium intake 51 dietary acrylamide 51 degenerative neurological diseases 51 placenta accreta 51 REACH Registry 51 randomized metastatic breast 51 nonfatal stroke 51 CHD 51 depressive symptoms 51 biologically plausible 51 induced cardiomyopathy 51 prognostic indicator 51 VLDL cholesterol 51 coronary atherosclerosis 51 osteoporosis 51 CRBSI 51 antiplatelet medications 51 insulin resistance precursor 51 perinatal mortality 51 Metabolic syndrome 51 bulimia nervosa 51 Alzheimers disease 51 elevated depressive symptoms 51 Hilakivi Clarke 51 bone thinning 51 Dr. Edward Giovannucci 51 2 diabetes T2D 51 sporadic ALS 51 atypical femur fractures 51 systolic dysfunction 51 hypothyroidism 51 plasma lipids 51 Calcium supplementation 51 hereditary hemochromatosis 51 occupational exposures 51 Atrial fibrillation AF 51 adenotonsillectomy 51 neovascular AMD 51 Major Depressive Disorder 51 Fatty Liver Disease 51 Chronic constipation 51 streptococcal infections 51 Mayo Clinic neurologist 51 dyslipidemias 51 microvascular dysfunction 51 neuropsychological deficits 51 Asymptomatic 51 chronic prostatitis chronic 51 epigenetic mechanisms 51 cytomegalovirus infection 51 Heredity 51 statins 51 TZDs 51 angina myocardial infarction 51 Cholesterol Levels 51 serous ovarian cancer 51 oral clefts 51 Bibbins Domingo 51 gene variation 51 sonographic diagnosis 51 chemoprevention 51 HDL2 51 cranial irradiation 51 Howard Sesso 51 atopic asthma 51 elevated hsCRP 51 Dr Zorbas 51 fasting plasma glucose 51 Abdominal fat 51 transfusion syndrome 51 juvenile idiopathic arthritis JIA 51 orofacial clefts 51 lipid metabolism 51 Nocturia 51 IDDM 51 hereditary nonpolyposis colorectal cancer 51 Susan B. Shurin 51 glucocorticoid therapy 51 Chronic Kidney Disease 51 adequate calcium intake 51 atopic diseases 51 Cardiovascular Outcomes 51 confounding factors 51 sCJD 51 Modifiable risk 51 use disorders AUDs 51 apoE4 51 VTE 51 Menopausal hormone therapy 51 Acid reflux disease 51 breast cancer metastasis 51 chronic pelvic 51 HbA 1c 51 CARDIA study 51 dietary calcium